ZBH logo

ZIMMER BIOMET HOLDINGS INC

ZBHNYSE
🏆 #616 by market capEarnings Nov 3 · PreUS Equity
$91.33▼ $0.28 (−0.31%)
After hours · at close
🔔
Track ZBH
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 0.3%
7d▼ 2.8%
14d▼ 7.2%
30d▼ 9.5%
ytd▲ 1.6%
1y▼ 7.1%
🏦Market Cap
$17.67B
Mid Cap
📈Revenue Growth (YoY)
+7.2%
Slowing
📊Gross Margin
69.9%
High
💵FCF Margin
21.5%
Strong
⚖️P/S Ratio
2.1x
Cheap
Otter Score
68
Fair

Trading Snapshot

Day Range
$90.29 – $93.12
52-Week Range
$79.12 – $106.88
Volume
$2.47B
Avg Volume
$3.06B
Shares Outstanding
193.5M
Next Earnings
Nov 7, 2026

Fundamentals Snapshot

Annual Revenue
$8.23B
Last Q Revenue
$2.18B
P/E Ratio
22.0
P/S Ratio
2.1x
EPS (TTM)
$4.20
Dividend Yield
1.05%
Dilution (1yr)
−0.9%

Why Investors Own ZBH

  • ✓High-growth profile — revenue up -5.3% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 76% gross margin and 20% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ZBH logo

ZIMMER BIOMET HOLDINGS INC

ZBH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8.2B▲ +7.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
61.6%▼ −13.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.4B▲ +6.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.5B▲ +28.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
198.1M▼ −0.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$6.9B▼ −$1.2B YoY
StockOtter · stockotter.space

About ZIMMER BIOMET HOLDINGS INC

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
68/100

Analyst Ratings

ⓘ
Consensus
Hold
33 analysts
Strong Buy3
Buy8
Hold22
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

🚀
MarketWatch·2h ago

ZIMMER BIOMET HOLDINGS INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Bloomberg·5h ago

Analysts lift ZBH price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

ZIMMER BIOMET HOLDINGS INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.